News
The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications.
The drugmaker released its second-quarter earnings report early Wednesday as it vowed to cut costs amid intensifying ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...
Booming sales of Wegovy powered the company to become Europe's most valuable, but it has lost over $400 billion in market ...
Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.
The market is driving prices on GLP-1 drugs down, and an added benefit is lower spending on food.
Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone ...
Eli Lilly ( LLY -0.24%) has been a terrific investment in recent years. Thanks to significant clinical progress and outstanding financial results, the company has become the largest healthcare player ...
Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there? Here's what to know.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results